Intelligence

#Business #Closed Loop Medicine #NVIDIA #Start-ups

Closed Loop Medicine joins NVIDIA Inception programme

Closed Loop Medicine has joined the NVIDIA Inception accelerator programme, designed to nurture start-ups and early-stage companies revolutionising industries with technological advancements. The programme supports all stages of a start-up’s life cycle, providing access to the latest tools, expertise, and a network of venture capitalist investors,… Read More

#Business & Investment #News #Start-up Zone

Cell and gene therapy infographic
#Cell and gene therapy #Drug discovery #GMP #Infographic

Overcome your cell and gene therapy (GMP) challenges

Download this interactive infographic to: Discover ways to navigate your contamination, compliance, reproducibility, monitoring and scalability challenges Identify which critical factors and equipment you should consider to help succeed in a GMP environment Unlock access to an extensive collection of helpful resources… Read More

#Intelligence #Resources

Whitepaper: Fuelling the future: Precision medicine innovation and the role of ecosystems
#Biotech hubs #Drug discovery #Drug discovery hotspots #Life sciences #Precision medicine #UK

Fuelling the future: Precision medicine innovation and the role of ecosystems

This whitepaper, Fuelling the future: Precision medicine innovation and the role of ecosystems, examines how the future of drug discovery and precision medicine can be enhanced by life science ecosystems such as those created by the UK’s leading property developer to the science and technology sectors, Bruntwood SciTech. In the whitepaper,… Read More

#Resources

#Biotech hubs #Drug discovery hotspots #Life sciences #Switzerland

Drug discovery hotspots: What is the secret to Switzerland’s success? (p2)

DDW’s Diana Spencer takes a closer look into why Switzerland is such a life sciences powerhouse and how Swiss researchers are advancing new technology and tackling modern health challenges. OECD data places Switzerland second in the world for biotechnology R&D intensity1, and in 2021, the country… Read More

#Exclusive Content #Market Reports

#Biotech hubs #Drug discovery hotspots #Life sciences #Switzerland

Drug discovery hotspots: What is the secret to Switzerland’s success? (p1)

DDW’s Diana Spencer takes a closer look into why Switzerland is such a life sciences powerhouse and how Swiss researchers are advancing new technology and tackling modern health challenges. OECD data places Switzerland second in the world for biotechnology R&D intensity1, and in 2021, the country… Read More

#Exclusive Content #Market Reports

#Advanced Therapies

Infographic: Overcome your cell and gene therapy (GMP) challenges

Download this interactive infographic to: Discover ways to navigate your contamination, compliance, reproducibility, monitoring and scalability challenges Identify which critical factors and equipment you should consider to help succeed in a GMP environment Unlock access to an extensive collection of helpful resources… Read More

#Infographics

Drug Discovery World report on Neuroscience
#Drug discovery #In Focus Report #Market reporting #Neuroscience

Neuroscience: Advances in research and opportunities ahead

Download this In Focus eReport to learn more about the drug discovery innovation and advancement taking place in this field. The eReport includes: A global market overview including prevalence, value and future outlook A scientific article on developing therapeutics targeting biomolecular condensates An interview with ApconiX’s Director and Co-founder, Professor… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

#Exsilio Therapeutics #Financing #Genetics / genomics #mRNA #Start-ups

mRNA-based drug company launches with $82 million

Genomic medicine developer Exsilio Therapeutics has emerged from stealth with $82 million in Series A financing. The funding was co-led by Novartis Venture Fund and Delos Capital, with participation from OrbiMed, Insight Partners, JP Morgan Life Sciences Private Capital, CRISPR Therapeutics, Innovation Endeavors, Invus, Arc Ventures,… Read More

#Business & Investment #News #Start-up Zone

Case Study: Improving physiological relevance in neurological disease drug development
#Assays #Drug development #Drug discovery #iPSC #Neurology

Improving physiological relevance in neurological disease drug development

In this case study, hear from Elise Malavasi, PhD, a Principal Scientist at leading contract research organisation Concept Life Sciences. The interview highlights their need to develop assays that are amenable to long term use to support their clients with drug development, and how bit.bio’s deterministically programmed ioMicroglia have helped… Read More

#Resources

Drug stability testing eBook
#Drug development #Drug discovery #Stability characterisation #Testing

Drug Stability Testing 101

Learn about the key principles, methodologies and regulatory requirements of drug stability testing with our recently developed eBook: ‘Drug Stability Testing 101’. This eBook has been prepared by scientists and industry professionals at Thermo Fisher Scientific to provide you with valuable insights and practical knowledge to help you optimise this critical… Read More

#Resources

#Cancer research #Drug development #Drug discovery #Guide

DDW Global Cancer Research Guide 2024

Download the exclusive Guide and read about: Where is the global innovation and opportunity in cancer drug discovery? How is technology expediting the development of new cancer drugs? CRISPR-Cas and its use in cancer research What lies ahead for cancer research?… Read More

#DDW eBooks #DDW Guides

Neuroscience Parkinson's disease
#Bayer #Biogen #BlueRock Therapeutics #Cell therapy #Ionis Pharmaceuticals #Mission Therapeutics #Neuroscience #Parkinson's #Small molecul #Stem cells #Vaxxinity #Vesper Bio

Exploring new frontiers in Parkinson’s Disease   

With debilitating symptoms including tremor, slow movement, rigidness and pain, Parkinson’s disease remains one of the most feared neurodegenerative conditions. DDW’s Megan Thomas reports on the latest clinical progress as pharma and biotech search for new therapies for this currently incurable condition.  Parkinson’s is the most common movement disorder, affecting… Read More

#Exclusive Content #Trends & Analysis